JAMA Dermatology

Papers
(The H4-Index of JAMA Dermatology is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Treatment With Topical Sirolimus for Recurrent Lymphatic Malformation of the External Urethral Meatus873
Clinical and Pathological Spectrum of Prurigo Pigmentosa in Central European Individuals261
Widespread Erythematous Plaques With Prominent Telangiectases168
JAMA Dermatology165
Treatment of Verruca Plana With Topical Combination of Calcipotriol and Fluorouracil144
Error in Author Name137
Error in Author Surname in Byline128
Melanoma Screening119
Can Serum Biomarkers for Prurigo Nodularis Expose Pathophysiology or Just Treatment Response?112
Treatment With Ataluren for Wound Healing and Health Complications in a Patient With Junctional Epidermolysis Bullosa109
Prevalence and Patient Characteristics of Ectodermal Dysplasias in Denmark103
Assessment of Cutaneous Vasculitis and Quality of Life93
Frequency of Skin Biopsies for Psoriasis by Race and Ethnicity93
Group Omitted From Article Byline93
Exanthematous Eruption in a Patient With Known Chronic Graft-vs-Host Disease and Recent Measles Vaccination90
JAMA Dermatology87
Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in Adults83
Parental E-Cigarette Use and Pediatric Atopic Dermatitis75
Nicotinamide for Skin Cancer Chemoprevention67
Subclinical Synovitis Among Patients With Psoriasis Without Musculoskeletal Involvement66
Ultraprocessed Food Intake and Psoriasis63
Smoking Cessation and Risk of Hidradenitis Suppurativa Development63
Outcomes Associated With Combination Shaving and Cryosurgery Treatment in Patients With Keloid Scars62
Skin Cancer Care in US Veterans—Serving Those Who Served62
Alopecia Areata61
Adalimumab Monotherapy vs Adalimumab With Methotrexate for Psoriasis59
Prevalence of Contact Allergens in Natural Skin Care Products From US Commercial Retailers56
Current State of Dermatology Mobile Applications With Artificial Intelligence Features53
Pregabalin for Neuropathic Pain and Itch in Recessive Dystrophic Epidermolysis Bullosa52
Perceptions of US-Based Muslim Patients of Their Dermatology Care52
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice51
Treatment of Severe Palmoplantar Pustular Psoriasis With Bimekizumab51
Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database50
Tofacitinib for Treatment of Acquired Reactive Perforating Collagenosis50
Biomarkers of Tretinoin Precursors and Tretinoin Efficacy in Patients With Moderate to Severe Facial Photodamage49
Recurrence Rate of Melanoma In Situ Excised With a 5-mm Excisional Margin47
Cutaneous Angiosarcoma46
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records45
Association of Treatment With Secukinumab With Exacerbation of Dermatomyositis in a Patient With Psoriasis45
Treatment of Kimura Disease With Dupilumab44
Immune Checkpoint Inhibitors in Field Cancerization and Keratinocyte Cancer Prevention44
Patient-Reported Outcomes in Dermatology44
Novel Treatments for Chronic Erythema Multiforme Inform Translational Science and Disease Pathogenesis43
0.14745807647705